1. Home
  2. FENG vs PLUR Comparison

FENG vs PLUR Comparison

Compare FENG & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phoenix New Media Limited

FENG

Phoenix New Media Limited

N/A

Current Price

$1.76

Market Cap

32.7M

Sector

Industrials

ML Signal

N/A

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$2.88

Market Cap

31.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FENG
PLUR
Founded
1998
2001
Country
China
Israel
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
31.5M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
FENG
PLUR
Price
$1.76
$2.88
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
6.5K
48.1K
Earning Date
11-12-2025
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$106,947,410.00
$1,326,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
N/A
N/A
Revenue Growth
9.17
121.74
52 Week Low
$1.28
$2.82
52 Week High
$3.65
$7.13

Technical Indicators

Market Signals
Indicator
FENG
PLUR
Relative Strength Index (RSI) 44.14 41.70
Support Level $1.81 $2.90
Resistance Level $2.02 $3.02
Average True Range (ATR) 0.11 0.23
MACD 0.00 0.00
Stochastic Oscillator 55.21 20.00

Price Performance

Historical Comparison
FENG
PLUR

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: